Error: 500: HTTP/2 500 CLINICAL TRIAL REVIEW - JDDonline - Journal of Drugs in Dermatology

Home
Issues
Topics
CME
- CME Activities
Multimedia
Info
Inclusive Derm Atlas
- Online Gallery
- Digital Edition
Subscribe Now
Log In

x-twitter facebook linkedin instagram

CLINICAL TRIAL REVIEW

June 2008 | Volume 7 | Issue 6 | 605 | Copyright © June 2008

Abstract

1

Download Original Article
Bulk Order Reprints
Request Image Permission

Search page

Advertisement

Popular

A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne July 2, 2026
JDD Podcasts: Catch-up Now! July 1, 2026
Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors June 30, 2026
JDD in the News: Distinguishing Malassezia Folliculitis from Acne Vulgaris June 29, 2026
Safety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles June 26, 2026

Advertisement

News Topics

Inclusive Derm Atlas
Atopic Dermatitis
CME
Featured Articles
Issue Highlights
Oats in Skincare
Oncoderm
Pigmentary Disorders
Psoriasis
Skin of Color

CONTACT US | FEEDBACK | TERMS | COOKIE POLICY | PRIVACY | EDITORIAL POLICY | ADVERTISING POLICY | MANAGE PREFERENCES | YOUR PRIVACY CHOICES

News Topics

Inclusive Derm Atlas
Atopic Dermatitis
CME
Featured Articles
Issue Highlights
Oats in Skincare
Oncoderm
Pigmentary Disorders
Psoriasis
Skin of Color

Journal of Drugs in Dermatology

About Us
Contact Us
Contact Sales
Editorial Board
eJDD
Institutional, Library, & Corporate Subscriptions
Log In
Open Access
Permissions Request
Podcast Sponsorship
Subscription Info
Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

twitter
facebook
linkedin
instagram

Home
Issues
Topics
CME
- CME Activities
Multimedia
Info
Inclusive Derm Atlas
- Online Gallery
- Digital Edition
Subscribe Now
Log In

Search

x-twitter
facebook
linkedin
instagram